Relationships between neuropsychiatric symptoms, subtypes of astrocyte activities, and brain pathologies in Alzheimer's disease and Parkinson's disease is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01 AG024904
National Institutes of Health
Grant: U24AG072701
National Institutes of Health
Grant: 1K01AG086665
NIA NIH HHS
Grant: K01 AG086665
NIA NIH HHS
Grant: P30 AG066515
DOD ADNI
Grant: W81XWH-12-2-0012
National Institutes of Health
Grant: 5K01AG086665-02
Characterizing biopsychological mismatch during cognitive training in mild cognitive impairment as a means of improving transfer
Allergan
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 5U24AG072701-03
Network For Emotional Wellbeing And Brain Aging (NEW Brain Aging)
ADNI
Avid Radiopharmaceuticals
BIAL
Biogen
Capsida Biotherapeutics
Coave Therapeutics
Euroimmun
GSK
Golub Capital
Johnson & Johnson Pharmaceutical Research & Development LLC.
Neuron23
Pfizer
Pfizer Inc.
AbbVie
Araclon Biotech
Eisai Inc.
Eli Lilly
GE Healthcare
Michael J. Fox Foundation for Parkinson's Research
NIBIB NIH HHS
National Institute on Aging
Neuropore
Sanofi
Takeda
Teva
University of Southern California
Alzheimer's Therapeutic Research Institute
BlueRock Therapeutics
Canadian Institutes of Health Research
Gain Therapeutics
Michael J. Fox Foundation for Parkinson's Research
National Institute of Biomedical Imaging and Bioengineering
Neurotrack Technologies
Voyager Therapeutics
Weston Family Foundation
Alzheimer's Disease Neuroimaging Initiative
Amathus Therapeutics
Insitro
Laboratory for Neuro Imaging at the University of Southern California
Meso Scale Discovery
NeuroRx Research
Northern California Institute for Research and Education
Sun Pharma Advanced Research Company
Verily
Allergan
Cerevel Therapeutics
Cogstate
Denali
Eli Lilly and Company
Fujirebio
IXICO Ltd.
Lumosity
Merck
Mission Therapeutics
Piramal
Takeda Pharmaceutical Company
UCB
4D Pharma
Alzheimer's Association
BioLegend
Calico Labs
CereSpir, Inc.
H. Lundbeck A/S
Handl Therapeutics
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Jazz Pharmaceuticals
Johnson & Johnson Innovative Medicine
Novartis Pharmaceuticals Corporation
Piramal Imaging
Roche
AcureX
Biohaven
CIHR
Celgene
Edmond J. Safra Foundation
Elan Pharmaceuticals, Inc.
Genentech
Genentech, Inc.
Lundbeck
Meso Scale Diagnostics, LLC.
Prevail Therapeutics
Transition Therapeutics
Abbvie
Aligning Science Across Parkinson's
Aligning Science Across Parkinson's
Alzheimer's Association
Alzheimer's Disease Neuroimaging Initiative
AskBio
BioArctic
DaCapo Brainscience
Fujirebio US
GlaxoSmithKline
Neurocrine Biosciences
Servier
Vanqua Bio
Yumanity Therapeutic
FWCI
6.94
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals